ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
66,892.75
-0.28%
S&P 500
5,303.27
0.12%
Dow Jones
40,003.59
0.34%
US Dollar vs Yen
155.675
0.00%
Brent Oil
83.76
0.00%
Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. USOTC
  6. Defence Therapeutics Inc (QB) (DTCFF)

  7. Defence Therapeutics Inc (QB) (DTCFF) ニュース

DTCFF

Defence Therapeutics (QB) (DTCFF)

Defence Therapeutics Inc (QB)
から:
次の項目別のソート:
 Showing the most relevant articles for your search:USOTC:DTCFF
日付受信時刻ニュースソース見出しコード企業名
2022/02/1700 : 00InvestorsHub NewsWireDEFENCE RETAINS CATO SMS TO ADVISE ON ITS  PHASE I CLINICAL TRIAL ON ACCUTOXTM FOR BREAST CANCERUSOTC:DTCFFDefence Therapeutics Inc (QB)
2022/01/2622 : 49InvestorsHub NewsWireDefence's AccumTM-HPV vaccine formulation (AccuVAC-PT009) activates a 36-fold higher humoral response compared to Gardasil-9USOTC:DTCFFDefence Therapeutics Inc (QB)
2021/12/0102 : 32InvestorsHub NewsWireDEFENCE THERAPEUTICS VACCINES AND PROGRAM DEVELOPMENTUSOTC:DTCFFDefence Therapeutics Inc (QB)
2021/11/2322 : 24InvestorsHub NewsWireDEFENCE THERAPEUTICS CANCER VACCINE ACCUVAC-D001 MANUFACTURING TARGETS MELANOMA AND BREAST CANCERUSOTC:DTCFFDefence Therapeutics Inc (QB)
2021/11/1001 : 50InvestorsHub NewsWireDEFENCE THERAPEUTICS APPOINTS DR. RIAM SHAMMAA TO ITS BOARD OF DIRECTORSUSOTC:DTCFFDefence Therapeutics Inc (QB)
2021/11/0321 : 11InvestorsHub NewsWireVACCINE RESULTS: DEFENCE THERAPEUTICS REPORTS SUCCESSFUL COMPLETION OF ITS COVID-19 VACCINE ACCUVAC-PT001 TOXICOLOGY STUDIES IN RABBITSUSOTC:DTCFFDefence Therapeutics Inc (QB)
2021/10/1322 : 15InvestorsHub NewsWireDEFENCE THERAPEUTICS ACCUMTM VARIANTS IN VITRO STUDY INCREASES THE POTENCY OF T-DERUXTECAN ADC BY 5-FOLD ON BREAST CANCERUSOTC:DTCFFDefence Therapeutics Inc (QB)
2021/10/0622 : 32InvestorsHub NewsWireDEFENCE THERAPEUTICS PREPARES FOR PHASE I TRIAL TO TEST ITS DC CANCER VACCINE, ACCUVAC-D002, AGAINST MELANOMAUSOTC:DTCFFDefence Therapeutics Inc (QB)
2021/09/2921 : 30InvestorsHub NewsWireDEFENCE THERAPEUTICS TO FINALIZE ITS OBJECTIVES TO INITIATE A PHASE I TRIAL AGAINST BREAST CANCERUSOTC:DTCFFDefence Therapeutics Inc (QB)
2021/09/2023 : 01InvestorsHub NewsWireDEFENCE THERAPEUTICS SUCCESSFULLY ENGINEERED AND TESTED A NOVEL INTRANASAL COVID-19 VACCINE FORMULATION IN ANIMALSUSOTC:DTCFFDefence Therapeutics Inc (QB)
2021/09/1421 : 13InvestorsHub NewsWireDEFENCE THERAPEUTICS SUCCESS IN TESTING IT'S COVID-19 ACCUVAC-PT001 VACCINE IN A NON-RODENT MODELUSOTC:DTCFFDefence Therapeutics Inc (QB)
2021/09/0720 : 35InvestorsHub NewsWireDEFENCE THERAPEUTICS DEVELOPMENT PROGRAM TO ENGINEER A NEW HPV VACCINE INITIATEDUSOTC:DTCFFDefence Therapeutics Inc (QB)
2021/09/0123 : 39InvestorsHub NewsWireThe vaccination specialist is about to become popularUSOTC:DTCFFDefence Therapeutics Inc (QB)
 Showing the most relevant articles for your search:USOTC:DTCFF

最近閲覧した銘柄

POLO
BTTBTC
LSE
RSH3
3x Rd Shell
NASDAQ
AAXCSXX
Morgan Stanley Finance L...
TSXV
DTG.H
Dynamic Technologies
EU
3612T
3612T
BIT
UIE584
Unicredit Bank
ASX
OLI
Olivers Real Food
USOTC
WAWIF
Wallenius Wilhelmsen ASA (PK)
BOV
RAPTQ100
RAPTQ100 Ex:10
NASDAQ
DAGM
BIT
F12027
Vontobel Financial Produ...
MRTX
BITXETH
BITIFEX
NASDAQ
INOD
Innodata
LSE
IVZ
USOTC
SILEF
Silver Elephant Mining (PK)
BIT
UB740C
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有